Authors: Ando, M Tamayose, K Sugimoto, K Oshimi, K

Citation: M. Ando et al., Secondary myelodysplastic syndrome after treatment of prostate cancer withoral estramustine, AM J HEMAT, 67(4), 2001, pp. 274-275

Authors: Mochizuki, H Hayakawa, H Migita, M Shibata, M Tanaka, R Suzuki, A Shimo-Nakanishi, Y Urabe, T Yamada, M Tamayose, K Shimada, T Miura, M Mizuno, Y

Citation: H. Mochizuki et al., An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease, P NAS US, 98(19), 2001, pp. 10918-10923

Authors: Tamayose, K Sugimoto, K Ando, M Oshimi, K

Citation: K. Tamayose et al., Disappearance of chromosomal abnormalities and recovery of hematopoiesis after immunosuppressive therapy for hypoplastic refractory anemia with excess of blasts, BLOOD, 97(8), 2001, pp. 2524-2524

Authors: Satoh, W Hirai, Y Tamayose, K Shimada, T

Citation: W. Satoh et al., Site-specific integration of an adeno-associated virus vector plasmid mediated by regulated expression of rep based on Cre-loxP recombination, J VIROLOGY, 74(22), 2000, pp. 10631-10638

Authors: Sugimoto, K Tamayose, K Takagi, M Yamada, K Sasaki, M Mizutani, S Oshimi, K

Citation: K. Sugimoto et al., Activation of an ataxia telangiectasia mutation-dependent intra-S-phase checkpoint by anti-tumour drugs in HL-60 and human lymphoblastoid cells, BR J HAEM, 110(4), 2000, pp. 819-825

Authors: Sugimoto, K Sasaki, M Tamayose, K Oshimi, K

Citation: K. Sugimoto et al., Inhibition of p34(cdc2) dephosphorylation in DNA damage- and topoisomeraseII inactivation-induced G2 arrests in HL-60 cells, BR J HAEM, 105(3), 1999, pp. 720-729